Development of biopharmaceuticals in plant expression systems: Cloning, expression and immunological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco

Vaccine

Volumn 17, Issue 23-24, 1999, Pages 3020-3029

  Tackaberry, E S ^a,b   Dudani, A K ^a,b   Prior, F ^a   Tocchi, M ^c   Sardana, R ^b   Altosaar, I ^b   Ganz, P R ^a,b  

^a Bureau of Biologics   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c CANADIAN BLOOD SERVICES   (Canada)

Author keywords

Human cytomegalovirus; Oral vaccines; Transgenic tobacco

Indexed keywords

CYTOMEGALOVIRUS VACCINE; GLUTENIN; PLANT EXTRACT; RECOMBINANT PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; EXPRESSION VECTOR; FIBROBLAST CULTURE; GLYCOPROTEIN SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MOLECULAR CLONING; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC PLANT;

ANIMALS; BLOTTING, SOUTHERN; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; CYTOMEGALOVIRUS; HUMANS; IMMUNODOMINANT EPITOPES; PLANTS, GENETICALLY MODIFIED; PLANTS, TOXIC; RECOMBINANT PROTEINS; SEEDS; TOBACCO; TRANSGENES; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS;

EID: 0033529588     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00150-4     Document Type: Article

References (43)

1. Pen J. Comparison of host systems for the production of recombinant Proteins. Owen M.R.L., Owen P. Transgenic plants: a production system for industrial and pharmaceutical proteins. 1996;149-167 John Wiley and Sons, New York, NY.
2. Moffat A.S. Exploring transgenic plants as a new vaccine source. Science. 268:1995;658-660.
3. Kusnadi A.R., Nikolov Z.L., Howard J.A. Production of recombinant proteins in transgenic plants: practical considerations. Biotech Bioeng. 56:1997;473-484.
4. Mason H.S., Ball J.M., Shi J.J., Jiang X., Estes M.K., Arntzen C.J. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci USA. 93:1996;5335-5340.
5. Mason H.S., Haq T.A., Clements J.D., Arntzen C.J. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine. 16:1998;1336-1348.
6. Thanavala Y., Yang Y.F., Lyons P., Mason H.S., Arntzen C. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc Natl Acad Sci USA. 92:1995;3358-3361.
7. Tacket C.O., Mason H.S., Losonsky G., Clements J.D., Levine M.M., Arntzen C.J. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nature Med. 4:1998;607-609.
8. Ho M (editor). Cytomegalovirus: biology and infection, 2nd ed. New York: Plenum Medical Book Co. 1991.
9. Landini M.P. Antibody responses to human cytomegalovirus proteins. Rev Med Virol. 2:1992;63-72.
10. Britt W.J. Vaccines against cytomegalovirus: time to test. Trends Microbiol. 4:1996;34-38.
11. Tackaberry E.S., Hamel J., Larose Y., Brodeur B.R. Anti-idiotypic mimicry of a neutralizing epitope on the glycoprotein B (gB) complex of human cytomegalovirus. J Virol. 67:1993;6815-6819.
12. Spaete R.R., Thayer R.M., Probert W.S., Masiarz F.R., Chamberlain S.H., Rasmussen L., Merigan T.C., Pachl C. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology. 167:1988;207-225.
13. Yamashita Y., Shimokata K., Mizuno S., Daikoku T., Tsurumi T., Nishiyama Y. Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus. J Virol. 70:1996;2237-2246.
14. Kari B., Liu Y.N., Lussenhop N., Stinski M., Gehrz R. Structure and composition of a family of human cytomegalovirus glycoprotein complexes designated gC-1. J Gen Virol. 71:1990;2673-2680.
15. Britt W.J., Vugler L.G. Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. J Virol. 63:1989;403-410.
16. Qadri I., Navarro D., Paz P., Pereira L. Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus. J Gen Virol. 73:1992;2913-2921.
17. Kari B., Gehrz R. Biochemical and immunological analysis of discontinuous epitopes in the family of human cytomegalovirus glycoprotein complexes designated gC-I. J Gen Virol. 72:1991;1975-1983.
18. Norais N., Hall J.A., Gross L., Tang D., Kaur S., Chamberlain S.H., Burke R.L., Marcus F. Evidence for a phosphorylation site in cytomegalovirus glycoprotein gB. J Virol. 70:1996;5716-5719.
19. Fish K.N., Soderberg-Naucler C., Nelson J.A. Steady-state plasma membrane expression of human cytomegalovirus gB is determined by the phosphorylation state of Ser900. J Virol. 72:1998;6657-6664.
20. Adeli K., Altosaar I. Compartmentalization of seed reserve proteins - proposed discriminatory factors. FEBS Lett. 178:1984;193-198.
21. Bewley J.D., Black M. Seed development and maturation. Bewley J.D., Black M. Seeds: physiology of development and germination. 1994;35-115 Plenum Press, New York.
22. Okita T.W., Hwang Y.S., Hnilo J., Kim W.T., Aryan A.P., Larson R., Krishnan H.B. Structure and expression of the rice glutelin multigene family. J Biol Chem. 264:1989;12573-12581.
23. Zhao Y., Leisy D.J., Okita T.W. Tissue-specific expression and temporal regulation of the rice glutelin Gt3 gene are conferred by at least two spatially separated cis-regulatory elements. Plant Mol Biol. 25:1994;429-436.
24. Leisy D.J., Hnilo J., Zhao Y., Okita T.W. Expression of a rice glutelin promoter in transgenic tobacco. Plant Mol Biol. 14:1989;41-50.
25. Jefferson R.A. Assaying chimeric genes in plants: the GUS gene fusion system. Plant Mol Biol Rep. 5:1987;387-405.
26. Ganz P.R., Dudani A.K., Tackaberry E.S., Sardana R., Sauder C., Cheng X., Altosaar I. Expression of human blood proteins in transgenic plants: the cytokine GM-CSF as a model protein. Owen M.R.L., Owen P. Transgenic plants: a production system for industrial and pharmaceutical proteins. 1996;281-297 John Wiley and Sons, New York.
27. Sardana RK, Ganz PR, Dudani AK, Tackaberry ES, Cheng X, Altosaar I. Synthesis of recombinant human cytokine GM-CSF in the seeds of transgenic tobacco plants. In: Cunningham C, Porter A (editors). Methods in biotechnology, Vol.3. Totowa, NJ: Humana Press. 1997. p. 77-87.
28. Ganz P.R., Dudani A.K., Tackaberry E.S., Sardana R., Sauder C., Cheng X., Altosaar I. Plants as factories for producing human blood proteins. Can Soc Trans Med Bull. 7:1995;112-121.
29. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. 1989.
30. Datla R.S.S., Hammerlindl J.K., Panchuk B., Pelcher L.E., Keller W. Modified plant transformation vectors with the wild-type gene encoding NPTII. Gene. 122:1992;383-384.
31. Zambryski P. Basic processes underlying Agrobacterium mediated DNA transfer to plant cells. Annu Rev Genet. 22:1988;1-30.
32. Horsch R.B., Fry J.E., Hoffmann N.L., Eichholtz D., Rogers S.G., Fraley R.T. A simple and general method for transferring genes into plants. Science. 227:1985;1229-1231.
33. Robert L.S., Donaldson P.A., Ladaique C., Altosaar I., Arnison P.G., Fabijanski S.F. Antisense RNA inhibition of β-glucuronidase gene expression in transgenic tobacco plants. Plant Mol Biol. 13:1989;399-409.
34. Draper J., Scott R. The isolation of plant nucleic acids. Draper J., Scott R., Armitage P. Plant genetic transformation and gene expression: a laboratory manual. 1988;214-216 Blackwell Scientific Publications, Oxford.
35. Larose Y., Tackaberry E.S., Brodeur B.R. Human monoclonal antibodies to cytomegalovirus recognize viral epitopes on the surface of viral-infected cells. Hum Antibodies Hybridomas. 2:1991;65-73.
36. Cranage M.P., Smith G.L., Bell S.E., Hart H., Brown C., Bankier A.T., Tomlinson P., Barrell B.G., Minson T.C. Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type I glycoprotein H. J Virol. 62:1988;1416-1422.
37. Scott R., Draper J., Jefferson R., Dury G., Jacob L. Analysis of gene organization and expression in plants. Draper J., Scott R., Armitage P. Plant genetic transformation and gene expression: a laboratory manual. 1988;263-339 Blackwell Scientific Publications, Oxford.
38. Iglesias V.A., Moscone E.A., Neuhuber F., Michalowski S., Phelan T., Spiker S., Matzke M., Matzke A.J. Molecular and cytogenic analyses of stably and unstably expressed transgenic loci in tobacco. Plant Cell. 9:1997;1251-1264.
39. Albright L.M., Yanofsky M.F., Leroux B., Ma D.Q., Nester E.W. Processing of the T-DNA of Agrobacterium tumefaciens generates border nicks and linear, single-stranded T-DNA. J Bacteriol. 169:1987;1046-1055.
40. Shalaby W.S.W. Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies. Clin Immunol Immunopathol. 74:1995;127-134.
41. Manganaro M., Ogra P.L., Ernst P.B. Oral immunization: turning fantasy into reality. Int Arch Allergy Appl Immunol. 103:1994;223-233.
42. Service R.F. Triggering the first line of defense. Science. 265:1994;1522-1524.
43. Arntzen C.J. Pharmaceutical foodstuffs. Nature Med Vacc Suppl. 4:1998;502-513.